A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
Clinical trial NCT03895372 · COMPLETED
Trial details
- NCT number
- NCT03895372
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-27
- Primary completion
- 2020-05-21
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.